Cite
HARVARD Citation
Pizzuti, L. et al. (2018). Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab. Cancer biology & therapy. 19 (4), pp. 328-334. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pizzuti, L. et al. (2018). Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab. Cancer biology & therapy. 19 (4), pp. 328-334. [Online].